December 20, 2014 11:59 PM ET

Pharmaceuticals

Company Overview of Invivis Pharmaceuticals Inc.

Company Overview

Invivis Pharmaceuticals Inc. engages in the research and development of oncology drugs for the treatment of cancer. It offers IVV-1001, an antiprogestin and anti-hormone used for the treatment of breast cancer. Invivis Pharmaceuticals Inc. was formerly known as Pharmalead Therapeutics Inc. The company is based in Bridgewater, New Jersey.

547 Meadow Road

Bridgewater, NJ 08807

United States

Phone:

908-818-9393

Fax:

888-591-1834

Key Executives for Invivis Pharmaceuticals Inc.

Co-Founder and Chief Operating Officer
Senior Vice President of Discovery
Member of Scientific Committee and Member of The Board of Directors
Member of Scientific Committee
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Murty Pharmaceuticals Incorporated United States
Ex-Lax, Inc. United States
Companion Pharma, Inc. United States
URL Pharma, Inc. United States
Apicore, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Invivis Pharmaceuticals Inc., please visit www.invivis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.